Publications by authors named "Liteng Lin"

Claim this Profile
S
SIRT or TACE in combination with Lenvatinib and PD-(L)1 inhibitor in high tumor burden hepatocellular carcinoma: a multicenter, retrospective, propensity score-matched study.
Jingjun Huang, Huimin Niu, Hui Zhang, Mingyue Cai, Zhiheng Wang, Liteng Lin

Int J Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib Combined with Tislelizumab and Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: A Phase II Study.
Licong Liang, Jingwen Zhou, Jingjun Huang, Yongjian Guo, Zhimei Zhou, Liteng Lin, Zhaoyi Lin

Immunotargets Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbial metabolism dysfunction induced by transarterial chemoembolization aggravates postprocedural liver injury in HCC.
Rui Li, Jianxin Liu, Feilong Ye, Siqin He, Jingjun Huang, Liteng Lin

J Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acid-responsive engineered bacteria with aberrant In-Situ anti-PD-1 expression for post-ablation immunotherapy of hepatocellular carcinoma.
Yue Li, Xiaobin Wang, Feilong Ye, Xiaoyang Hong, Ye Chen, Liteng Lin

Biomed Pharmacother· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial.
Xiaoyang Hong, Yongjian Guo, Wenbo Shi, Kangshun Zhu, Licong Liang, Liteng Lin

BMC Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib plus drug-eluting bead transarterial chemoembolization with/without hepatic arterial infusion chemotherapy for hepatocellular carcinoma larger than 7 cm with major portal vein tumor thrombosis: a multicenter retrospective cohort study.
Mingyue Cai, Licong Liang, Jian Zhang, Nianping Chen, Wensou Huang, Liteng Lin

Int J Surg· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CTLA-4 antibody self-presented dendritic cell nanovesicles boost the immunotherapy of hepatocellular carcinoma after microwave ablation.
Tan Li, Bo Li, Liteng Lin, Gengjia Chen, Xiaobin Wang

J Control Release· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation.
Song-Bin Guo, Yuan Meng, Liteng Lin, Zhen-Zhong Zhou, Hai-Long Li

Mol Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manganese oxide-constructed multifunctional biomimetic nanovaccine for robust tumor-specific T cell priming and chemodynamic therapy.
Tan Li, Gengjia Chen, Liteng Lin, Bo Li, Xiaobin Wang

Biomaterials· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbial-derived Urolithin A Targets GLS1 to Inhibit Glutaminolysis and Attenuate Cirrhotic Portal Hypertension.
Rui Li, Zhile Liu, Wensou Huang, Yongjian Guo, Chan Xie, Liteng Lin

Cell Mol Gastroenterol Hepatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver transplantation following two conversions in a patient with huge hepatocellular carcinoma and portal vein invasion: A case report.
Li-Cong Liang, Wen-Sou Huang, Zhao-Xiong Guo, Hong-Ji You, Yong-Jian Guo, Li-Teng Lin

World J Gastroenterol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study.
Mingyue Cai, Wensou Huang, Wei Liang, Yongjian Guo, Licong Liang, Liteng Lin

Liver Int· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence.
Ye Chen, Jiaxin Bei, Meijuan Chen, Weiguo Cai, Zhimei Zhou, Liteng Lin

Adv Healthc Mater· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and characterization of 3-in-1 multifunctional lipiodol-doped FeO@Poly (diallyl isophthalate) microspheres for arterial embolization, chemotherapy, and imaging.
Piaoyi Chen, Qinglin Xiao, Zhaoxiong Guo, Wei Liang, Ou Liu, Liteng Lin

Biomed Mater· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HBV suppresses macrophage immune responses by impairing the TCA cycle through the induction of CS/PDHC hyperacetylation.
Jiaxin Bei, Ye Chen, Qianbing Zhang, Xiaobin Wang, Liteng Lin

Hepatol Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms and therapeutic strategies to combat the recurrence and progression of hepatocellular carcinoma after thermal ablation.
Feilong Ye, Lulu Xie, Licong Liang, Zhimei Zhou, Siqin He, Liteng Lin

J Interv Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study.
Yongjian Guo, Jingqiang Wu, Licong Liang, Kangshun Zhu, Jingwen Zhou, Liteng Lin

Cancer Imaging· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Expression of Ten Eleven Translocation 1 Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Haopeng Wen, Tengfei Ji, Liteng Lin, Nan Cheng, Kangshun Zhu

Mediators Inflamm· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanodrug removes physical barrier to promote T-cell infiltration for enhanced cancer immunotherapy.
Zecong Xiao, Yitong Tan, Yujun Cai, Jinsheng Huang, Xiaobin Wang, Liteng Lin

J Control Release· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation.
Zecong Xiao, Tan Li, Xinyao Zheng, Liteng Lin, Xiaobin Wang

Bioact Mater· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib enhances anti-tumor efficacy of immune checkpoint inhibitor by regulating IFN-γ/NSDHL/SREBP1/TGF-β1 axis in hepatocellular carcinoma.
Lulu Xie, Mingyu Liu, Mingyue Cai, Wensou Huang, Yongjian Guo, Miaoling Lai, Liteng Lin

Biomed Pharmacother· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
Xiaobin Wang, Qiaoyun Zhang, Jingwen Zhou, Zecong Xiao, Jianxin Liu, Liteng Lin

J Immunother Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases.
Mingyu Liu, Lulu Xie, Yuying Zhang, Jianning Chen, Xiang Zhang, Miaoling Lai, Liteng Lin

Cell Death Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.
Mingyue Cai, Wensou Huang, Jingjun Huang, Wenbo Shi, Yongjian Guo, Liteng Lin

Front Immunol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study.
Jingjun Huang, Yongjian Guo, Wensou Huang, Xiaotao Hong, Yi Quan, Liteng Lin

J Hepatocell Carcinoma· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis